FOSTER CITY, Calif.--(BUSINESS WIRE)--Applied Biosystems (NYSE:ABI), an Applera Corporation business, and its joint-venture partner, MDS Analytical Technologies, a business unit of MDS Inc. (NYSE:MDZ) (TSX:MDS), today announced the availability of a suite of integrated mass spectrometry-based solutions for conducting targeted quantitative proteomics studies. Designed for Applied Biosystems/MDS Analytical Technologies’ industry-leading triple quadrupole and hybrid triple quadrupole/linear ion trap mass spectrometry systems, these solutions include software packages and consumables that enable scientists to more effectively quantify proteins in biomarker research or cell biology.
